Dupixent is already approved in the US for a variety of indications, going back to eczema in 2017 (and most ... Click here for more. In the age of AI, large data sets – like the treasure trove ...

2 Top Growth Stocks to Buy on the Dip was originally published by The Motley Fool ...

Sanofi’s Dupixent has shown there is a market for biologic drugs to treat eczema, and now Spain’s ... Click here for more. In the age of AI, large data sets – like the treasure trove of ...

In one study, a handful of people who took Dupixent (dupilumab) by injection had an eczema flare after being vaccinated for ... recommends that everyone age 6 months and older receive an updated ...

Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

In adults, eczema most commonly develops in the 20s or after age 50, according to the association. "As a population, we should continue our efforts to combat pollution, as it can have a ...

People living in areas with higher levels of air pollution are more likely to have eczema, according to a new study.

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...